Parkinson's disease and related α-synucleinopathies are brain amyloidoses

Annals of the New York Academy of Sciences

Volumn 991, Issue , 2003, Pages 107-110

  Trojanowski, John Q ^a   Lee, Virginia M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alpha synuclein; Neurodegenerative brain amyloidoses; Parkinson's disease; Synucleinopathies

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PROTEIN; UBIQUITIN;

ALPHA SYNUCLEINOPATHY; AMYLOIDOSIS; BRAIN AMYLOIDOSIS; BRAIN NERVE CELL; CELL INCLUSION; CONFERENCE PAPER; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENE MUTATION; GLIA CELL; HUMAN; NERVE DEGENERATION; NITRATION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; TRANSGENIC ANIMAL;

ANIMALIA;

EID: 0038727850     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07468.x     Document Type: Conference Paper

References (13)

1. LANG, A.E. & A.M. LOZANO. 1998. Parkinson's disease. New Engl. J. Med. 339: 1044-1053 and 1130-1143.
2. BONINI, N.M. 2002. Chaperoning brain degeneration. Proc. Natl. Acad. Sci. USA 99: 16407-16411.
3. CLAYTON, D.F. & J.M. GEORGE. 1999. Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res. 58: 120-129.
4. DICKSON, D.W. 2001. Alpha-synuclein and the Lewy body disorders. Curr. Opin. Neurol. 14: 423-432.
5. FEANY, M.B. 2000. Studying neurodgenerative diseases in flies and worms. J. Neuropath. Exper. Neurol. 59: 847-856.
6. GOEDERT, M. 2001. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2: 492-501.
7. TROJANOWSKI, J.Q. & V.M-Y. LEE. 2002. Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses. Neurotoxicology 23: 457-460.
8. AULUCK, P.K., H.Y.E. CHAN, J.Q. TROJANOWSKI, et al. 2002. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model of Parkinson's disease. Science 295: 865-868.
9. AULUCK, P.K. & N.M. BONINI. 2002. Pharmacological prevention of Parkinson's disease in Drosophila. Nat. Med. 8: 1185-1186.
10. HASEGAWA, M., H. FUJIWARA, T. NONAKA, et al. 2002. Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J. Biol. Chem. 277: 49071-49076.
11. HASHIMOTO, M., E. ROCKENSTEIN, M. MANTEE, et al. 2001. Beta-synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 32: 213-223.
12. MASLIAH, E., E. ROCKENSTEIN, I. VEINBERGS, et al. 2001. Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl. Acad. Sci. USA 98: 12245-12250.
13. PERL, D.P., C.W. OLANOW & D. CALNE. 1998. Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration. Ann. Neurol. 44: S19-S31.